Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy

NCT07256002 ·Status: ACTIVE_NOT_RECRUITING

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

NCT04492969 ·Status: UNKNOWN

A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC

NCT06503042 ·Status: NOT_YET_RECRUITING

Multicenter Observational Study of Advanced Non-small Cell Lung Cancer With Malignant Pleural Effusion

NCT04263688 ·Status: UNKNOWN

CTC in Lung Caner Patients With Bone Metastases

NCT04568291 ·Status: UNKNOWN ·Phase: NA

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

NCT06358222 ·Status: RECRUITING

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy

NCT06869239 ·Status: RECRUITING

Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer

NCT07166003 ·Status: RECRUITING

Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery

NCT05648370 ·Status: UNKNOWN

Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance

NCT05933863 ·Status: COMPLETED

Evaluation of Clinical Significance and Feasibility of CT Guided Biopsy of Double Site Lesions：A Preliminary Lung Centered Study

NCT04960631 ·Status: COMPLETED

Correlation Between Specific Gene Mutationand Local Immune Microenvironment and Immunotherapy Efficacy in NSCLC

NCT04405661 ·Status: UNKNOWN

Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy

NCT05636605 ·Status: RECRUITING

Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers

NCT01141686 ·Status: COMPLETED

cfDNA Methylation Assay for Clinical Evaluation of Patients With Stage IA Lung Cancer After Ablation Operation

NCT04413656 ·Status: UNKNOWN ·Phase: NA

Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer

NCT05979623 ·Status: COMPLETED

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

NCT03172156 ·Status: COMPLETED

Investigation on Predictive Molecular Markers of Efficacy for Front-line Immunochemotherapy in Advanced NSCLC

NCT04858828 ·Status: UNKNOWN

Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer

NCT06907160 ·Status: RECRUITING

Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer

NCT02941003 ·Status: UNKNOWN ·Phase: NA

Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients

NCT04229121 ·Status: UNKNOWN

Clinical Study on the Prevention of Driver Gene Negative Ib-IIIb Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

NCT05834413 ·Status: RECRUITING ·Phase: NA

Molecular Imaging Visualization of Tumor Heterogeneity in Non-small Cell Lung Cancer

NCT04553601 ·Status: UNKNOWN ·Phase: NA

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

NCT06613308 ·Status: NOT_YET_RECRUITING

Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma

NCT03938012 ·Status: UNKNOWN